Commenting yesterday on the Medicare Payment Advisory Commission’s draft recommendations for 2021, AHA said it supports the recommendation to provide current law market-basket updates for the hospital inpatient and outpatient prospective payment systems, but urged the commission to consider a higher update in light of the “sustained and substantial” negative Medicare margins hospitals face. The association said it supports the concept of appropriately linking quality performance to payment, but has significant concerns with the design of the Hospital Value Incentive Program. AHA also urged the commission to recommend a full market-basket update for long-term care hospitals, inpatient rehabilitation facilities and hospital-based skilled nursing facilities. Among other comments, the letter highlights access challenges faced by LTCH site-neutral patients, and urges MedPAC to analyze and report on access to care and clinical outcomes for these vulnerable patients. It also responds to the commission’s prior discussion on how to design a value incentive program for post-acute care.

Headline
The Centers for Medicare & Medicaid Services announced Sept. 25 that it will expand the Inpatient Rehabilitation Facility Review Choice Demonstration to…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027.…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
The AHA Aug. 17 provided comments to the Centers for Medicare & Medicaid Services on its proposed rule to codify in regulation the Medicare Drug Price…